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Abstract
Background: Homeostatic erythropoiesis leads to the formation of mature red blood cells under non-stress conditions, and
the production of new erythrocytes occurs as the need arises. In response to environmental stimuli, such as bone marrow
transplantation, myelosuppression, or anemia, erythroid progenitors proliferate rapidly in a process referred to as stress
erythropoiesis. We have previously demonstrated that heme oxygenase-1 (HO-1) deficiency leads to disrupted stress
hematopoiesis. Here, we describe the specific effects of HO-1 deficiency on stress erythropoiesis.
Methodology/Principal Findings: We used a transplant model to induce stress conditions. In irradiated recipients that
received hmox
+/2 or hmox
+/+ bone marrow cells, we evaluated (i) the erythrocyte parameters in the peripheral blood; (ii) the
staining intensity of CD71-, Ter119-, and CD49d-specific surface markers during erythroblast differentiation; (iii) the patterns
of histological iron staining; and (iv) the number of Mac-1
+-cells expressing TNF-a. In the spleens of mice that received
hmox
+/2 cells, we show (i) decreases in the proerythroblast, basophilic, and polychromatophilic erythroblast populations; (ii)
increases in the insoluble iron levels and decreases in the soluble iron levels; (iii) increased numbers of Mac-1
+-cells
expressing TNF-a; and (iv) decreased levels of CD49d expression in the basophilic and polychromatophilic erythroblast
populations.
Conclusions/Significance: As reflected by effects on secreted and cell surface proteins, HO-1 deletion likely affects stress
erythropoiesis through the retention of erythroblasts in the erythroblastic islands of the spleen. Thus, HO-1 may serve as a
therapeutic target for controlling erythropoiesis, and the dysregulation of HO-1 may be a predisposing condition for
hematologic diseases.
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Introduction
Erythropoiesis, the development of mature red blood cells
(RBCs), originates from pluripotent hematopoietic stem cells
(HSCs) and progresses through erythroblasts to the formation of
RBCs. Just prior to maturation, erythroblasts extrude their nucleus
and mature into reticulocytes. As reticulocytes, they exit the bone
marrow and enter blood capillaries to participate in oxygen
transport. Homeostatic erythropoiesis maintains normal hemato-
crit levels and occurs as needed to replace old and damaged
erythrocytes. In response to special needs, such as after bone
marrow (BM) transplantation, myelosuppression, or anemia, stress
erythropoiesis occurs as the body attempts to increase the
production of erythrocytes. This process occurs in part within
the spleen [1] and is regulated by several factors that are shared
with homeostatic erythropoiesis. These include erythropoietin,
iron, cytokines, cellular regulators, and adhesion molecules.
Factors that distinguish homeostatic and stress hematopoiesis are
less well described.
The heme oxygenase-1 enzyme (HO-1) is encoded by the hmox-1
gene and is an inducible stress enzyme that catalyzes heme
oxidation into carbon monoxide (CO), free ferrous iron, and
biliverdin. The free iron from this reaction is sequestered by ferritin,
and the biliverdin is rapidly converted into bilirubin by biliverdin
reductase[2]. COis a diffusible regulatorthat has beenlinkedto the
regulation of numerous cellular and tissue functions [3,4]. HO-1
facilitates iron reutilization in mammals [5] and modulates the
expression of cytokines [6] and adhesion molecules [7,8]. HO
activity has been implicated inthe controlof inflammation, immune
regulation and organ transplantation [9,10,11]. Genetic knockout
(KO) of HO-1 results in partial embryonic lethality and leads to a
number of hematological disorders in surviving mice, including
anemia, hypoferremia and tissue accumulation of iron [5,10]. In a
rare human case, HO-1 deficiency was associated with thrombo-
cytosis, coagulation abnormalities, persistent hemolytic anemia,
iron deposition in tissues, and premature death [12,13].
We previously reported that HO-1 deficiency leads to disrupted
stress hematopoiesis of stem cells and progenitors [14]. Mice lacking
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+/2) showed accelerated hematopoietic
recovery from myelotoxic injury. However, hmox
+/2 HSCs were
ineffective in the radioprotection and serial repopulation of
myeloablated recipients. In this study we observed a threshold for
effective transplantation of HO-1 knockout bone marrow; too few
cells led to hematopoietic failure due to stem cell depletion,
transplantation using cell numbers above this threshold were
successful, but serial transplants from these recipient animals also
resulted in hematopoietic failure.
Here we describe the effects of HO-1 deficiency specifically on
stress erythropoiesis using cell numbers above the previously
described threshold. We used a transplant model to induce stress
conditions and demonstrated that HO-1 deletion affects stress
erythropoiesis. In the spleen, HO-1 participates in proper
erythroblast differentiation and optimal iron reutilization. Its
deficiency increases the number of TNF-a-expressing cells and
leads to a decrease of the CD49d levels in proerythroblasts. These
findings suggest that HO-1 deficiency might cause a premature
release of erythroblasts into the circulation.
Results
1- HO-1 haploinsufficiency disrupts erythrocyte
parameters in the peripheral blood
HO-1-deficient mice show a high level of embryonic lethality
[5], and therefore the effects of HO-1 haploinsufficiency were
studied as a means of assessing the intrinsic contribution of HO-1
in stress erythropoiesis following transplantation. Whole BM from
either hmox
+/+ or hmox
+/2 mice was transplanted into lethally
irradiated recipient mice.
Eight days after engraftment, the reticulocyte counts increased
rapidly in recipients of hmox
+/2 BM cells, reaching a level of
,250% of those in the recipients of hmox
+/+ BM cells
(1.2260.48610
5 per uL versus 0.4760.14610
5 per uL; n=5,
*P=0.031) (Figure 1A). In contrast, 15 days after engraftment, the
reticulocyte counts in recipients of hmox
+/2 BM cells were only
27% of those observed in the mice that received hmox
+/+ BM cells
(4.2261.35610
5 per uL versus 15.3863.75610
5 per uL; n=5,
**P=0.007) (Figure 1A). This is consistent with our previous
report in which we demonstrate accelerated hematopoiesis that
was not sustainable after transplant [14].
We also observed elevated hematocrits in mice that received
hmox
+/2 BM cells relative to those that received hmox
+/+ BM cells.
At day 7, mice that received hmox
+/2 BM cells had statistically
greater hematocrit levels than recipients of wild-type cells
(33.062.2% versus 29.660.5%; *P=0.047) (Figure 1B). However,
at day 15, the hematocrits from recipients of either hmox
+/2 or
hmox
+/+ BM cells (36.462.1% versus 38.261.2%) (Figure 1B) were
lower than those in the non-transplanted mice (39.0% versus
47.0%, data not shown).
Thesedata suggestthattherewasearly-acceleratederythropoiesis
in the recipients of hmox
+/2 BM cells. However, this level of
erythropoiesis could not be sustained, and the number of immature
erythrocytes declined prior to a full recovery from the blood loss.
Mice that received hmox
+/2 BM cells had statistically more
RBCs (7.160.5610
6 per uL versus 6.260.1610
6 per uL; n=5,
*P=0.041) at day 7 (Figure 1C), whereas their hemoglobin levels
were slightly, but not statistically significantly, higher (10.260.6 g/
dL versus 9.360.2 g/dL; n=5, P=0.055) compared to those of
mice that received hmox
+/+ BM cells (Figure 1D).
The ratios of the RBC count, hematocrit, and hemoglobin levels
between the mice that received hmox
+/2 and hmox
+/+ BM cells
decreased gradually over time from 1.13–1.15 (at day 4) to
0.92 - 0.95 (at day 15) (Figure 1E). These data show that there are
more hmox
+/2 BM cell-derived erythrocytes in the peripheral
blood than hmox
+/+ BM cells from day 4 to 10, and the opposite
from day 10 to 21. This suggests that hmox
+/2 BM cell-derived
erythrocytes might appear earlier in the peripheral blood than
those from hmox
+/+ BM cells.
2- HO-1 participates in proper erythroblast differentiation
The spleen and BM serve as reserves for accelerated hematopoi-
esis under conditions of hematopoietic stress. Loss of HO-1 did not
change the total spleen and BM cellularities (data not shown). To
further investigate whether HO-1 deficiency specifically affects
stress erythropoiesis, we adopted a flow cytometric assay and
analyzed cells from the BM and spleen of transplanted mice. Four
classes of erythroid precursors can be identified by the staining
intensities (low, medium (med), or high) of specific surface markers
upon maturation, as shown in Figure 2 and as previously described
[15]. Listed in order of the earliest to the most mature, these precur-
sors are the early proerythroblast (Ter119
medCD71
high) identified in
region a, the basophilic erythroblast (Ter119
highCD71
high)i n
region b, the late basophilic and polychromatophilic erythroblast
(Ter119
highCD71
med) in region c, and the orthochromatophilic
erythroblast (Ter119
highCD71
low) in region d.
At day 15 post-transplantation, the BM of mice engrafted with
hmox
+/2 cells presented decreased numbers of polychromatophilic
(regions c,,1.5-fold) and orthochromatophilic(region d,,1.9-fold)
populations compared with control mice engrafted with hmox
+/+
cells (Figure 2A, left panels). Interestingly, the spleens of mice
engrafted with hmox
+/2 cells presented decreased numbers of
proerythroblast (region a, ,3.5-fold), basophilic (region b, ,2-fold)
and polychromatophilic (region c, ,2.7-fold)populations compared
with the control animals (Figure 2A, right panel). Thus, the
proportions of total erythroid precursors analyzed in the BM of
hmox
+/+ and hmox
+/2 recipients were 27.4610.6% and 23.865.6%,
respectively (n=6, P=0.07) (Figure 2B). The proportions of total
erythroid precursors analyzed in the spleens of hmox
+/+ and hmox
+/2
recipients were 74.068.1% and 35.065.9%, respectively (n=6,
*P=0.002) (Figure 2B). Similar results were obtained at eight days
post-transplantation (data not shown).
These data indicated that HO-1 deletion resulted in deficient
erythroblast differentiation following transplantation of hmox
+/2
BM cells, both in the spleen and to a lesser extent in the BM. Given
these data, we focused on the spleen as a site of stress erythropoiesis.
3- HO-1 participates in optimal iron re-utilization
Iron is an essential component of heme synthesis and
hemoglobin formation. The majority of iron in erythropoiesis is
reutilized in the breakdown of heme from senescent erythrocytes.
Because HO-1 has an important iron-recycling role [5], we
investigated whether iron reutilization is optimal in the spleen after
the engraftment of HO-1-deficient BM cells.
To test this possibility, histological analysis of the spleen was
performed 14 days post-transplantation. Hemosiderin-laden mac-
rophages, accounted for approximately 2% of the total red pulp
nucleated cell population in the spleens of mice that received
hmox
+/2 BM cells, compared to ,1% in mice that received hmox
+/+
BM cells (Figure 3A, upper levels; see Methods for quantification).
Prussian blue staining showed an average of 2.6% of the splenic
cross-sectional area to be positive for iron in the recipients of
hmox
+/2 BM cells, compared to 0.9% in the recipients of hmox
+/+
BM cells (Figure 3B, lower levels).
The analysis of soluble iron in spleen homogenates showed the
total and free iron levels of mice that received hmox
+/2 BM cells to
be 323621 and 144618 ng/dL, respectively. This is 20% less
compared to the 399632 and 183612 ng/g observed in the
HO-1 in Stress Erythropoiesis
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+/+ BM cells (n=6, *P=0.025 and *P=0.021,
respectively) (Figure 3C). No significant differences were observed
in the plasma (data not shown).
Here, both the increase of the insoluble iron level (Figures 3A
and 3B) and the decrease of the soluble iron level (Figure 3C) in
the spleens of mice following HO-1
+/2 BM cell transplantation
suggest that HO-1 participates in optimal iron reutilization in
spleens after transplantation.
4- HO-1 deficiency increases the number of
TNF-a-expressing cells in the spleen
The proliferation and differentiation of erythroblasts occur in
specialized niches known as erythroblastic islands, which are
composed of central macrophages and erythroblasts at all stages of
differentiation [16]. Central macrophages secrete cytokines such as
TNF-a, which exerts an inhibitory effect on erythropoiesis
[17,18,19], and HO-1 has been shown to suppress the effects of
TNF-a [20,21].
To test whether HO-1 deficiency alters the expression of
TNF-a in stress erythropoiesis, we assessed the number of
Mac-1
+-cells expressing TNF-a in the spleens of recipients
following hmox
+/2 and hmox
+/+ BM cells transplantation
(Figure 4A). At day 15 post-engraftment, 16.062.9% of Mac-
1
+ TNF-a
+ cells were analyzed in the spleens of hmox
+/+ BM
cells-recipients, compared to 22.763.6% in those of hmox
+/2
BM cells-recipients (n=6; *P=0.016) (Figure 4B). This 40%
increase due to HO-1 deficiency suggests that TNF-a
Figure 1. HO-1 haploinsufficiency disrupts erythrocyte parameters in the peripheral blood. Lethally irradiated mice were transplanted
with 2610
7 hmox
+/+ or hmox
+/2 BM cells. Peripheral blood was drawn at each given time-point post-engraftment and was analyzed for the
reticulocyte count (A), hematocrit percentage (B), RBC count (C), and hemoglobin level (D). The ratios of the RBC counts, hematocrit percentages, and
hemoglobin levels of the hmox
+/2 to hmox
+/+ genotypes are plotted in (E) using the same data shown in (B-D). The mean 6 SEM is shown for five
mice per genotype; *P#0.05, **P#0.01.
doi:10.1371/journal.pone.0020634.g001
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poiesis in HO-1 deficiency.
5- HO-1 deficiency leads to a decrease of the CD49d level
in splenic proerythroblasts
The adherence of erythroblasts to central macrophages within
erythroblastic islands enables proper erythroblastic differentiation
[22]. This cell-to-cell interaction is mediated by a4b1 integrin and
its a-subunit CD49d in erythroblasts and vascular adhesion
molecule-1 (VCAM-1) in macrophages [23].
Using a flow cytometric assay, we confirmed that CD49d
expression decreased in a pattern following erythroblast matura-
tion, from the highest expression in immature (Ter119
low
CD71
high) cells to the lowest in the most differentiated erythro-
blasts (Ter119
highCD71
low) (Figure S1), consistent with previously
reports [24].
We then investigated the effect of HO-1 deficiency on the
CD49d expression in splenic erythroblasts following BM trans-
plantation. At day 15 post-transplantation, only 72% of hmox
+/2
Ter119
high CD71
high cells were CD49d
+, compared to 92% of
hmox
+/+ cells (n=6, *P=0.04) (Figure 5, upper panel). A more
drastic deviation was shown in the Ter119
high CD71
med
population, in which only 31% of hmox
+/2 cells were CD49d
+
compared to 59% of hmox
+/+ cells (n=6, **P=0.008) (Figure 5,
middle panel). All the cells were CD49d negative in the splenic
Ter119
highCD71
low populations (Figure 5, lower panel).
These results show that in this transplant model, HO-1
deficiency affects CD49d expression during splenic erythroblast
maturation.
Discussion
We have previously demonstrated that HO-1-deficient BM cells
provide inadequate radioprotection of lethally irradiated mice
[14], and we have suggested that the loss of one allele of HO-1
may be sufficient to maintain the steady-state metabolism of heme
but insufficient under conditions of stress [14].
In this study, we documented for the first time the importance of
HO-1 in stress erythropoiesis and address the mechanism of
hematopoietic failure. Using a transplant model to induce stress
conditions, we showed that HO-1 haploinsufficiency led to
disrupted erythroblast differentiation. This resulted in the
reduction, or loss, of immature red blood cells during differenti-
ation from proerythroblasts to the orthochromatophilic erythro-
blast stage. Stress erythropoiesis is usually characterized by an
Figure 2. HO-1 participates in proper erythroblast differentiation. (A) Representative FACS profiles of freshly isolated BM cells (left panels)
and splenic cells (right panels) from hmox
+/+ or hmox
+/2 BM cell recipients at day 15 post-transplantation are shown. Cells were labeled with
PE-conjugated anti-CD71 and PE-Cy7-conjugated anti-Ter119. Dead cells (stained positive with propidium iodide) and enucleated erythrocytes (with
low forward scatter) were excluded from the analysis. The regions (from left to right and then from top to bottom) distinctly differentiate four classes
of erythroid precursors (from the earlier to the most mature): proerythroblasts (Ter119
medCD71
high) in region a, basophilic erythroblasts
(Ter119
highCD71
high) in region b, late basophilic and polychromatophilic erythroblasts (Ter119
highCD71
med) in region c, and orthochromatophilic
erythroblasts (Ter119
highCD71
low) in region d. The engraftment of HO-1-deficient BM cells modifies the FACS profile of the erythroblastic BM and
splenic cells. (B) The frequencies of total erythroid precursors found in regions a, b, c and d in the BM and the spleens of hmox
+/+ or hmox
+/2 BM cell
recipients are shown. The transplantation of HO-1-deficient BM cells leads to a decrease in the erythroid precursor population. The mean 6 SEM is
shown for six mice per genotype; *P#0.05.
doi:10.1371/journal.pone.0020634.g002
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+ erythroblasts [1].
Here, we showed that HO-1 deficiency led to a ,50% decrease in
the Ter119
high erythroblastic population. It is interesting to note
that the disrupted erythroblast differentiation following the
transplantation of hmox
+/2 BM cells was more dramatic in the
spleen than in the BM. This spleen-selective change is consistent
with the convention that stress erythropoiesis relies on a
specialized population of stress erythroid progenitors that
primarily reside in the spleen [25,26,27,28,29].
We also demonstrated a 20% decrease of the free iron levels and
a 40% increase of the TNF-a+ cell count in the spleens of mice
that received hmox
+/2 BM cells compared to those that received
hmox
+/+ BM cells. These changes were not observed in the BM
(Cao, unpublished data). It is still unclear whether the increased
TNF-a expression is a feature of decreased stress erythropoiesis or
if it is associated with increased numbers of macrophages due to
decreased iron utilization. It has been recently shown that only a
subset of macrophages express HO-1 [30]. The activation of
macrophages by exposure to lipopolysaccaride (LPS) and either
GM-CSF or M-CSF leads to the generation of TNF-a and
IL-12p40-producing pro-inflammatory macrophages [M1 (GM-
CSF)] or IL-10-producing anti-inflammatory macrophages [M2
(M-CSF)], respectively. A different iron metabolism gene signature
is detected in the two macrophage types, with HO-1 being
preferentially expressed by M2 (M-CSF) macrophages [30]. Thus,
in our study, it appears that only a subset of macrophages might
have been affected by the HO-1 haploinsufficiency.
We demonstrated that HO-1 deficiency leads to a decrease of
the CD49d level in proerythroblasts. This finding suggests that
HO-1 deficiency might cause a premature release of erythroblasts
into the blood circulation. We speculate that the decreased levels
of CD49d effect immature erythroblasts to result in disrupted
erythroblast differentiation and an early release of these cells from
erythroblastic islands, subsequently leading to inadequate stress
erythropoiesis. Erythroblasts are known to express adhesion
molecules that undergo dynamic variation during differentiation.
These proteins mediate both erythroblast-to-erythroblast and
erythroblast-to-macrophage interactions, as well as attachments
to the extracellular matrix components. Two major receptors/
counter-receptors identified as mediating the cell-to-cell interac-
tions within erythroid islands are a4b1 integrin (VLA-4) in
erythroblasts and VCAM-1 in central macrophages [23]. The
a4b1 integrin has a critical role in erythropoiesis by holding
maturing precursors in close association with the marrow stroma
[31,32,33,34,35]. The a4 integrin sub-unit (CD49d) is essential to
maintaining normal hematopoiesis in the spleen and BM
microenvironments [36] and mediates the association between
primitive erythroblasts and fetal liver-derived macrophages [37].
HO-1 has already been shown to modulate the expression of
adhesion molecules [7,8], and it is interesting to note that patients
with sickle cell anemia have an increased level of CD49d
expression [38], suggesting that a reduction in the adhesive
properties may contribute to the premature release of erythrocytes
into the peripheral blood.
We suggest here that decreased CD49d expression affects
splenic HO-1-deficient erythroblasts to lead to their premature
release into the circulation. Thus, the disrupted stress erythropoi-
esis described here might explain the ineffectiveness of hmox
+/2
Figure 3. HO-1 participates in optimal iron re-utilization. (A) H&E staining of the spleen sections from hmox
+/+ or hmox
+/2 cell recipients at
day 14 post-transplantation is shown. The arrows indicate hemosiderin-laden macrophages. The transplantation of HO-1-deficient BM cells leads to
an increase of hemosiderin. The magnification is 4006. The photograph shown is a representative of three experiments. (B) Prussian blue iron
staining of the spleen sections from hmox
+/+ or hmox
+/2 cell recipients at day 14 post-transplantation is shown. The transplantation of HO-1-deficient
BM cells leads to an increase of Prussian blue-positive cells. The magnification is 1006. The photograph shown is a representative experiment out of
the three that were performed. (C) The total and free iron levels in the splenic homogenates from hmox
+/+ or hmox
+/2 cell recipients at day 14 post-
transplantation are shown. The transplantation of HO-1-deficient BM cells leads to a decrease of soluble iron. The mean 6 SEM is shown for six mice
per genotype; *P#0.05.
doi:10.1371/journal.pone.0020634.g003
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that the HO-1 deficiency upset the self-renewal/differentiation
balance toward improper differentiation, prematurely depleting
the HSC reserve and releasing immature erythroblasts.
These results have implications in human hematological
diseases and their treatment. The promoter of the human hmox
gene is characterized by (GT)n repeats, with commonly occurring
length polymorphisms affecting the gene expression that have been
associated with a wide variety of diseases [39]. For example,
shorter repeats are associated with increased susceptibility to some
cancers and cerebral malaria, but these also have better liver and
kidney transplant survival, whereas long GT repeat polymor-
phisms cause a lower expression of HO-1 but are associated with
emphysema, miscarriages, and stroke [39]. It has been document-
ed that patients with myelodysplastic syndrome (MDS) present
macrophages with increased levels of TNF-a [40] and hemato-
poietic progenitors with reduced expression levels of CD49d [41].
It is intriguing that HO-1 deficiency shares some of the features of
MDS, and it will be important to investigate whether the
polymorphisms of HO-1 affect physiologic and pathologic human
erythropoiesis in similar manners as in MDS patients. We
anticipate that this research will not only lead to a better
understanding of the role of HO-1 in stress hematopoiesis but will
also suggest the clinical relevance of HO-1 as a target of novel
therapies for the treatment of human hematological pathologies.
Materials and Methods
1- Mice
FVB/NJ recipient mice were obtained from Charles River
Laboratories (Wilmington, MA, USA). hmox
2/2 and hmox
+/+ mice
were previously described [10]. All the experiments were set up
when the animals were 10 weeks old. Comparisons of hmox
+/2 and
hmox
+/+ mice were always conducted using littermates. The mice
werehoused inthe ResearchAnimal Facility atStanford University,
and all experiments were conducted under strict adherence to
institutional guidelines, as approved by the Animal Care and Use
Committee at Stanford University (APLAC #12323).
2- Purification of hematopoietic cells
Whole blood (200 mL) was drawn from the retro-orbital sinus
into EDTA-coated microhematocrit tubes (Sarstedt, Numbrecht,
Figure 4. HO-1 deficiency increases the number of TNF-a-expressing cells. (A) Representative FACS profiles of freshly isolated splenic cells
from hmox
+/+ or hmox
+/2 BM cell recipients at day 15 post-transplantation are shown. Cells were labeled with and PE-conjugated anti-TNF-a and
PE-Cy7-conjugated anti-Mac-1. Dead cells (stained positive with propidium iodide) were excluded from the analysis. The engraftment of HO-1-
deficient BM cells modifies the FACS profile of Mac-1 TNF-a-stained splenic cells. (B) The frequencies of Mac-1
+ TNF-a
+ splenic cells from hmox
+/+ and
hmox
+/2 BM cell recipients are shown. The transplantation of HO-1-deficient BM cells leads to an increase of the Mac-1
+ TNF-a
+ splenic population.
The mean 6 SEM is shown for six mice per genotype; *P#0.05.
doi:10.1371/journal.pone.0020634.g004
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Department of Comparative Medicine at Stanford University
for measurements of erythrocyte parameters. Blood counts and
erythrocyte indices were determined using an automated
hematology analyzer (Abbott Cell Dyne 3500, Abbott Park, IL,
USA). To obtain splenic cells, the spleen was dissected, and a
single cell suspension was generated by gently squishing the spleen
in a small volume of phosphate buffered saline (PBS). To recover
cells from the mouse BM, the marrow was flushed out of the tibia,
femur, and humerus using a syringe with PBS, filtered through a
70-mm mesh filter (BD Biosciences, San Jose, CA, USA) to remove
debris and pelleted by centrifugation. RBC contamination was
removed using an RBC-lysis buffer containing ammonium
chloride in 0.01 M Tris.
3- Bone marrow transplantation
In preparation for transplant, recipient mice (FVB/NJ) at two
months of age were lethally irradiated (one single dose of
11 Gy). The following day, isolated BM cells (2610
7)f r o m
hmox
+/2 or hmox
+/+ mice were intravenously injected into the
tail veins of recipient animals under methoxyflurane anesthesia.
Under these conditions, over 98% of the cells in the BM and
spleens of recipients are donor-derived at day 6 or later after
transfer [14]. Thus, flow cytometric assays were performed with
minimal interference from residual host cells, resolving the
distinct stages of erythroid differentiation as previously de-
scribed [15].
4- Phenotyping and flow cytometry
For erythroid cell subset analyses, splenic and BM cells were
stained with PE-conjugated anti-CD71 (BD Biosciences), PE-Cy7-
conjugated anti-Ter119 (eBioscience, San Diego, CA, USA), and
FITC-conjugated anti-CD49d (Affinity BioReagents, Rockford,
IL, USA). For TNF-a detection, splenic cells were first stained with
PE-Cy7-conjugated anti-Mac-1 (BD Biosciences). After fixation
and permeabilization, splenic cells were stained with PE-
conjugated anti-TNF-a (CALTAG Laboratories, Burlingame,
CA, USA). All stained cells were analyzed using the LSR
instrument (BD Biosciences) and FlowJo software (Tree Star
Inc., Ashland, OR, USA).
5- Histological staining for iron
Spleens were fixed in 4% paraformaldehyde, dehydrated in
ethanol, embedded in paraffin, sectioned and mounted onto glass
slides. Sections were stained either by hematoxylin and eosin
(H&E) or Prussian blue according to standard protocols. High-
resolution photomicrographs of six non-overlapping areas were
taken at 2006 magnification (2,59061,920 pixels representing
0.37508 mm
2) with a digital microscope camera system (Power-
shot G9, Canon, Lake Success, NY, USA; AxioVision 4.7.0.0,
Mu ¨nchen, Germany). Each photomicrograph was imported into
and processed by digital imaging software (UTHSCSA ImageTool
for Windows 3.00, San Antonio, TX, USA). The total area of iron
staining divided by the total area of the photomicrograph field
(expressed as a percentage per 2006photomicrograph field) was
determined for each of the six photomicrographs. The mean
percentage of iron staining was determined by averaging the
results from the six photomicrographs.
6- Iron level measurements
Spleens, which primarily contains erythroid cells, were homog-
enized in 19 volumes of PBS. Homogenates were centrifuged at
16,1006g for 2 min to remove cellular debris (including insoluble
hemosiderin iron), and supernatants were collected to measure
total and free iron. Iron measurements were performed and
analyzed at Analytics Inc. (Gaithersburg, MD, USA).
Figure 5. HO-1 deficiency leads to a decrease of the CD49d
level in splenic proerythroblasts. Representative FACS histograms
of basophilic (Ter119
highCD71
high), polychromatophilic (Ter119
high
CD71
med), and orthochromatophilic (Ter119
highCD71
low) splenic eryth-
roblasts from hmox
+/+ or hmox
+/2 BM cell recipients labeled with a FITC-
conjugated anti-CD49d are shown at day 15 post-transplantation. The
average frequencies of CD49d-positive cells in the different fractions of
splenocytes are indicated for both HO-1 genotypes. The mean 6 SEM is
shown for six mice per genotype; *P#0.05, **P#0.01.
doi:10.1371/journal.pone.0020634.g005
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Quantitative data are expressed as the mean 6 SEM. All
statistical analyses were performed on raw data for each group by
one-way analysis of variance followed by a Student’s t test.
Differences among groups were considered to be significant if the
probability of error was less than 0.05. The numbers of animals
used for each analysis are mentioned in the figure legends, in
addition to the effective P-values.
Supporting Information
Figure S1 Representative FACS histogram of CD49d staining in
splenic proerythroblasts (Ter119
medCD71
high), basophilic erythro-
blasts (Ter119
highCD71
high), polychromatophilic erythroblasts
(Ter119
highCD71
med) and orthochromatophilic erythroblasts
(Ter119
highCD71
low). The frequency of CD49d-positive cells
decreases with erythroblast maturation.
(TIF)
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